Medline Inc. Class A common stock (MDLN) is a publicly traded the market company. As of November 18, 2026, MDLN trades at $37.59 with a market cap of $34.42B and a P/E ratio of 0.00. MDLN moved -3.78% today. Year to date, MDLN is -3.39%; over the trailing twelve months it is flat. Its 52-week range spans $31.37 to $50.88. Analyst consensus is strong buy with an average price target of $47.50. Rallies surfaces MDLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for MDLN, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $37.59 |
| Market Cap | $34.42B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.88 |
| 52-Week Low | $31.37 |
| Volume | 8.19M |
| Avg Volume | 0 |
| Revenue (TTM) | $29.94B |
| Net Income | $887.00M |
| Gross Margin | 26.20% |
17 analysts cover MDLN: 0 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $47.50.